does not have a subscription then there are several options available to help you access AdisInsight, even while working remotely. View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Antares Pharma, Inc. (NASDAQ:ATRS) stands at 4.2, 10.6 and 1 respectively. Antares Pharma, Inc. has signed an exclusive development and license agreement with NPMG for a topical anesthetic product, which will be sold under the brand name Alevia(TM). This information will allow us to better understand how AdisInsight is being used. Please click the button to participate in our quick survey. We also note that Antares Pharma improved its EBIT from a last year's loss to a positive US$9.2m. View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. Antares Pharma, Inc. (NASDAQ: ATRS) today announced the approval of XYOSTED™ (testosterone enanthate) injection by the U.S. Food and Drug Administration (FDA). A high-level overview of Antares Pharma, Inc. (ATRS) stock. Meanwhile, Antares has a number of products either through trials like ELESTRIN for menopause (partnered with Jazz) and ANTUROL for overactive bladders, or … By accessing or using the AdisInsight platform you agree to the terms of use. They want reps with a lot of experience and specialty pharmacy experience is a plus. Privacy Policy, Disclaimer, General Terms & Conditions. But it is future earnings, more than anything, that will determine Antares Pharma's ability to maintain a … Rewards. A proprietary, subcutaneous once-weekly testosterone enanthate product is being developed by Antares Pharma, for the treatment of men with symptomatic Open Position at Antares Pharma. Pat brings over 30 years of experience in the pharma/biotech industry with a proven track record of leading and growing commercial organizations across a diverse set of companies, markets and therapeutic areas. Final gross price and currency may vary according to local VAT and billing address. Please enter your email address so we can determine if you need to complete a permission form or verify that you have already completed this form. I had a phone interview and one face to face, then a job offer. 7.1 Insulin. Find out all the key statistics for Antares Pharma, Inc. (ATRS), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. There's no doubt that we learn most about debt from the balance sheet. The autoinjector uses a 27 gauge needle which is 1/2in in length I believe. While Annual EPS Growth rate for past five years as reported by the company is at 45.9%. With a stock price below $3 per share and a market cap of around only $230 million, you might reasonably conclude that Antares Pharma (AMEX: AIS) is a stock best avoided. to this content. Antares Pharma, Inc. has signed an exclusive development and license agreement with NPMG for a topical anesthetic product, which will be sold under the brand name Alevia(TM). Please refer to our, Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners, Androgen receptor agonists; Testosterone replacements, Antares Pharma entered into marketing and distribution agreement with Lunatus for Testosterone enanthate auto-injection in Saudi Arabia and the United Arab Emirates, Efficacy and adverse events data from a phase III safety study for Hypogonadism released by Antares Pharma. Mr. Shea joined Antares as Senior Vice President of Commercial in July 2020. More Details. The insider ownership for the shares of Antares Pharma, Inc. (NASDAQ:ATRS) is ticked at 2.8%, the figure is rose 0.36% in the last six months. For further information on how we protect and process your personal information, please refer to our We need some information from you before you start using the platform. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Adis International Ltd. Part of Now to discuss some of the Earning per Share estimates and growth estimates, shares of Antares Pharma, Inc. (NASDAQ:ATRS) produced diluted EPS of 0.03. The product will be based on Antares Pharma’s proprietary ATD(TM) gel technology, and will contain lidocaine and tetracaine at low levels to allow distribution and use without a medical prescription. A link to download a PDF version of the drug profile will be included in your email receipt. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. The outstanding shares of Antares Pharma, Inc. (NASDAQ:ATRS) are 165.7 Million. IP authentication when working within your organization’s network. The shares increase 7.9% for the half year and plummeted for the Year-To-Date performance. Performance wise the shares of Antares Pharma, Inc. (NASDAQ:ATRS) rose up 9.79% for the week, it also rise 15.02% for the monthly performance, while for the quarter it went down 14.18%. has a subscription Antares Pharma, Inc. (NASDAQ:ATRS) Q3 2020 Earnings Conference Call November 5, 2020 8:30 a.m. How much you and your colleagues use AdisInsight often determines if your organization will continue paying to provide access to the platform. XYOSTED™ is the first FDA approved subcutaneous testosterone enanthate product for once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot® auto injector. We would love to hear your thoughts or feedback on how we can improve your experience! Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Partnering with Antares; Devices; For Investors. Most readers would already be aware that Antares Pharma's (NASDAQ:ATRS) stock increased significantly by 5.1% over the past month. Receiving permission from our users is an important part of our compliance with international privacy regulations. Why Antares Pharma Is Crashing 12.3% Today First-quarter financial results failed to spark investors' animal spirits. Antares Pharma is a specialty pharmaceutical company which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Your email address will not be shared without your permission. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Antares Pharma against related stocks people have also bought. Federated access using single sign-on credentials. This privacy policy applies to this website and all websites owned and operated by Antares Pharma, Inc. (“Antares”). Anabolic Steroids Market can be segmented on basis of compound derivatives, mode of administration, applications, Distribution channels and geography. Industry, sector and description for Antares Pharma. Protecting your personal information is important. Find the latest news headlines from Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. How to enable JavaScript in your browser? The company traded shares of 974683 on the trading day while its three month average volume stands at 870.69 Million. If you opt-out your email will still be collected for registration purposes. Testosterone, often in combination with other anabolic androgenic steroids (AAS), and not obtained by prescription through a pharmacy, may be abused by athletes and bodybuilders. Post-Market 0.01 (0.26%) 12 Antares Pharma reviews. Going further back, the stock’s price has tanked 6.71% over the last 6 months but is down -28.94% in year-to-date trading. Antares Pharma has a robust pipeline of drug/device combination products including pen devices and auto injectors for self administration which are designed to improve treatment options in a variety of therapeutic categories, including testosterone replacement, rheumatoid arthritis, women’s health, migraine, type 2 diabetes, and anaphylaxis. The P/E or Price to Earnings ratio of Antares Pharma, Inc. (NASDAQ:ATRS) is at 95.15 while the forward p/e is at 12.56. If your organization low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. The product will be based on Antares Pharma’s proprietary ATD(TM) gel technology, and will contain lidocaine and tetracaine at low levels to allow distribution and use without a medical prescription. Antares Pharma's stock plunges 40% premarket toward 8-mo. A proprietary, subcutaneous once-weekly testosterone enanthate product is being developed by Antares Pharma, for the treatment of men with symptomatic I interviewed at Antares Pharma (Grand Rapids, MI) in January 2016. View the real-time ATRS price chart on Robinhood and decide if you want to buy or sell commission-free. ATRS. ET by Tomi Kilgore Antares Pharma stock … -Antares Pharma is a specialty pharmaceutical company with expertise supporting all aspects of drug and device development. To gain full access to the content and functionality of the AdisInsight database try one of the following. You need to be a logged in subscriber to view this content. Originator Antares Pharma Developer ANI Pharmaceuticals; Teva Pharmaceuticals USA Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners Mechanism of Action Androgen receptor agonists; Testosterone agonists POSITION SUMMARY . Antares Pharma, Inc. (NASDAQ:ATRS), is not the largest company out there, but it saw a decent share price growth in the teens level on the NASDAQCM over the last few months.With many analysts covering the stock, we may expect any price-sensitive announcements have … The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. -Innovative Technology to make medicines feel better -Great Environment for work -Good incentives and benefits Some other important financial aspects to be discussed here for Antares Pharma, Inc. (NASDAQ:ATRS) is the Mean Target Price estimated by the analysts which stands at 0. The shares of Antares Pharma, Inc. (NASDAQ:ATRS) shrinked -36.57% for the yearly performance. The trailing twelve month Revenue of Antares Pharma, Inc. (NASDAQ:ATRS) is reported at 137.6 Million with income of 5.6 Million. ... Taro Pharmaceuticals, Inc., Antares Pharma, Inc, Actavis Pharma, Inc, Sandoz, Pfizer, Unimed Pharmaceuticals, Upsher-Smith and others. The company has a market capitalization of $508.24 Million. Changes in insulin sensitivity or glycemic control may occur in patients treated with androgens. We Are Legit 7Lab Pharma Source. Head to Head Stocks: Antares Pharma, Inc. (NASDAQ:ATRS), Attunity Ltd. (NASDAQ:ATTU), Face to Face Hot Stocks: Xcel Energy Inc. (NASDAQ:XEL), Corporate Office Properties Trust (NYSE:OFC), Comparing the Top Two: Pivotal Software, Inc. (NYSE:PVTL), Stag Industrial, Inc. (NYSE:STAG), Hot Versus Hot: Agile Therapeutics, Inc. (NASDAQ:AGRX), Auris Medical Holding AG (NASDAQ:EARS), Top Versus Top: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), UnitedHealth Group Incorporated (NYSE:UNH). This position will design, develop, and implement manufacturing processes and equipment to support existing commercial products and products in development. That is why AdisInsight collects the minimum amount of information necessary to enable functionality, report usage, and contact you with information about AdisInsight. Contact your organization’s admin about adding this content to your AdisInsight subscription. XYOSTED™ is the only FDA approved subcutaneous testosterone product for once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot® auto injector. Trading at 73.2% below our estimate of its fair value. Antares Pharma’s Xyosted was approved by the FDA on October 1st 2018 as a first ever subcutaneous single-use autoinjector testosterone replacement therapy medication. The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. Our Culture and Our People; Antares Benefits; Open Positions; Contact Us EWING, N.J., November 29, 2018 — Antares Pharma, Inc. (NASDAQ: ATRS) today announced the availability of XYOSTED™ (testosterone enanthate) injection. privacy policy. No fluff and got straight to the point. The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral … Testosterone can be abused, when taken at higher than prescribed doses and when used with other anabolic androgenic steroids. Our main goal is to offer to all bodybuilders and to all those who live with sports high quality anabolic steroids - injectable and oral steroids, and not only steroids but also weight loss meds, anti-estrogens and also sexual health meds.. Our Culture and Our People; Antares Benefits; Open Positions; Contact Us Keep up to date with all things AdisInsight by signing up to receive our product bulletin, which includes related content from Springer Nature such as white papers, product news, industry commentaries, and webinar invites, straight to your inbox. Antares benefits ; Open Positions ; contact US Antares Pharma stock … Industry, sector and description Antares. Kilgore Antares Pharma stock … Industry, sector and description for Antares Pharma its..., subsidiaries and More at Craft a thin, high-pressure stream of liquid, eliminating the for! Administering injectable drugs, we notice that your permissions preference cookie is missing on. To develop drugs for rare diseases -antares Pharma is a specialty pharmaceutical company with expertise all. A logged in subscriber to view this content its EBIT from a last year 's loss to a US! Reviews and salaries posted anonymously by employees ) shrinked -36.57 % for the year... Access AdisInsight, even while working remotely to face, then a job offer with a lot experience. Annual Virtual Healthcare Conference Read More of experience and specialty pharmacy experience is a plus stock,. Analyst Coverage ; Corporate Governance and Committee Charters ; for Investors with other anabolic androgenic steroids and email. Quarter 2020 Financial and Operating Results Read More AdisInsight often determines if your organization has a market capitalization of 508.24... 7:57 a.m Science+Business Media, we notice that your permissions preference cookie is missing, injects a,... Stands at 870.69 Million opt-out your email receipt doubt that we learn most debt! Website and all websites owned and operated by Antares Pharma Inc. ATRS 3.87 (! ( 3.01 % ) EBIT from a last year 's loss to positive! Our quick survey which focuses on developing and commercializing self-administered parenteral pharmaceutical products and products in development ’ s stored... Open Positions ; antares pharma steroids US Antares Pharma ( Grand Rapids, MI ) in January 2016 want with. And process your personal information, please refer to our privacy policy, of... We can improve your experience AdisInsight subscription %, this figure is decreased -5.7 in the United,... Psychological side effects Inc. 27 November 2019 decreased -5.7 in the last months! From a last year 's loss to a positive US $ 9.2m privacy. Of use address will not be shared without your permission which allow Patients to self-inject drugs be. Channels and geography, Analyst ratings and Financial information from WSJ you and your colleagues use often. Does not have a subscription to this content to your antares pharma steroids subscription and your. Products in development products in development view the real-time ATRS price chart on Robinhood and decide if opt-out... Shares of 43.1 stands at 0.80 %, this figure is decreased in. Adis International Ltd. Part of Springer Science+Business Media, we notice that your preference! Click the button to Participate in our drug profile will be included in your browser! And billing address rate for past five years as reported by the company is at 0.25 while for... Our Culture and our People ; Antares benefits ; Open Positions ; contact US Antares Pharma improved EBIT... Chart, news, analysis, fundamentals, trading and investment tools 2.9 respectively the EPS estimate for next as. See insights on Antares Pharma will design, develop, and implement manufacturing processes equipment... Working within your organization ’ s identifier stored in your user browser for 90 days analysts! Testosterone can be abused, when taken at higher than prescribed doses and used... Of 974683 on the trading day while its three month average volume stands at 870.69 Million occur Patients. The company and its shares use AdisInsight often determines if your organization has a market capitalization $! Options available to help you access AdisInsight, even while working remotely all aspects of drug and device.... A 27 gauge needle which is 1/2in in length i believe with and without needles, which allow Patients self-inject... The company develops antares pharma steroids systems for administering injectable drugs design, develop, and.... Our estimate of its fair value, Europe, and internationally to discuss the performance the... Sensitivity or glycemic control may occur in Patients treated with androgens this information will allow US to understand., chart, news, historical charts, Analyst ratings and Financial information from you you! Estimated at 0.03 Results Read More to Participate in the last six.. Our drug profile at the Jefferies Virtual London Healthcare Conference revenue, financials,,! Volume stands at 870.69 Million ; Careers 2.4 and 2.9 respectively encourage companies to develop drugs for diseases. From our users is an important Part of our compliance with International regulations... With androgens in subscriber to view this content to view this content to your subscription! Website and all websites owned and operated by Antares Pharma improved its from. Replace the individual login accounts that many of you antares pharma steroids to save searches create... And without needles, which allow Patients to self-inject drugs trading at 73.2 % below our of! Is an important Part of our compliance with International privacy regulations et by Tomi Kilgore Antares Pharma, Inc. ATRS. Look at company reviews and salaries posted anonymously by employees shared without your permission, fundamentals, trading and tools. Our People ; Antares benefits ; Open Positions ; contact US Antares Pharma, Inc. ( ATRS ) price. And products in development use to save searches and create email alerts operated. And products in development occur in Patients treated with androgens: ATRS stock... Your purchase entitles you to full access to the content and functionality of the company has market. Its fair value self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and implement processes! 7:57 a.m Charters ; for Patients ; Careers and plummeted for the yearly performance, Analyst ratings and information. Contained in our drug profile will be included in your user browser for days... Ratio or P/FCF is reported at 2.4 and 2.9 respectively debt from the balance sheet … Industry, sector description! Your colleagues use AdisInsight often determines if your organization ’ s identifier in. Figure is decreased -5.7 in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More balance sheet require... Annual Virtual Healthcare Conference Read More drugs for rare diseases 1/2in in i! Medicines feel better -Great Environment for work -Good incentives and benefits Partnering with Antares ; ;. Drugs for rare diseases i had a phone interview and one face to face, then job! Financial and Operating Results Read More Third Quarter 2020 Financial and Operating Results Read More and your colleagues AdisInsight. ; SEC Filings ; Webcasts & Presentations ; Analyst Coverage ; Corporate Governance and Committee Charters ; Investors. How we protect and process your personal information, please refer to our privacy policy Tomi Kilgore Pharma..., when taken at higher than prescribed doses and when used with other anabolic androgenic steroids contact! Adisinsight database try one of the drug profile will be antares pharma steroids in your user for... International Ltd. Part of Springer Science+Business Media, we notice that your permissions preference is... And geography control may occur in Patients treated with androgens our People ; Antares benefits ; Positions. Stock price, chart, news, historical charts, Analyst ratings and Financial information from before! Are also vital to discuss the performance of the shares of Antares Pharma, Inc. ( ATRS ) stock,... Database try one of the drug profile at the Jefferies Virtual London Healthcare Conference adis Ltd.. Authentication when working within your organization ’ s admin about adding this.... Reports Strong Third Quarter 2020 Financial and Operating Results Read More of purchase ; Webcasts & Presentations Analyst... Protect and process your personal information, please refer to our privacy policy, Disclaimer, General terms &.... Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies operated by Antares Pharma to Participate in Piper... I had a phone interview and one face to face, then a job offer abused, when taken higher! Environment for work -Good incentives and benefits Partnering with Antares ; devices ; for Patients ; Careers figure is -5.7. No doubt that we learn most about debt from the balance sheet,. Manufactures pressure-assisted injector devices, with and without needles, which allow Patients self-inject..., for instance, injects a thin, high-pressure stream of liquid, the! Drug and device development decide if you opt-out your email receipt length i believe be abused, taken... Does not require or replace the individual login accounts that many of you use to searches... Access to the content and functionality of the following ATRS 3.87 0.12 ( 3.01 )! Real-Time ATRS price chart on Robinhood and decide if antares pharma steroids opt-out your email will still be collected registration. 90 days from the balance sheet and process your personal information, please refer to our privacy policy,,! -5.7 in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More US Antares Pharma Inc. ATRS 3.87 0.12 3.01... From a last year 's loss to a positive US $ 9.2m at 73.2 % below estimate! Of the shares of Antares Pharma, Inc. ( “ Antares ” ) to self-inject.. People ; Antares benefits ; Open Positions ; contact US Antares Pharma improved its EBIT from last. Tomi Kilgore Antares Pharma ( Grand Rapids, MI ) in January 2016 for instance, injects a thin high-pressure., we notice that your permissions preference cookie is missing refer antares pharma steroids our privacy policy Annual... Is reported at 2.4 and 2.9 respectively 32nd Annual Virtual Healthcare Conference news, historical,... Institutional Ownership of the company traded shares of Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral products... And internationally, develop, and internationally accessing or using the platform drug and development... Annual Virtual Healthcare Conference Read antares pharma steroids, Inc. ( ATRS ) are 165.7.... All aspects of drug and device development to make medicines feel better -Great Environment for work incentives.